Biotech · Public company · Miami, FL, US
Longeveron Inc.
Ticker LGVN · SEC CIK 0001721484
Track this companyFree. Adds Longeveron Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials91 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline10
- Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)Phase 2 · FrailtyClinicalTrials.gov · fetched Nov 12, 2026
- Allogeneic MSCPhase 2 · Mild Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Fluzone High Dose VaccinePhase 2 · Aging FrailtyClinicalTrials.gov · fetched Nov 12, 2026
- Lomecel-B medicinal signaling cellsPhase 2 · Hypoplastic Left Heart SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Longeveron Mesenchymal Stem CellsPhase 2 · HLHSClinicalTrials.gov · fetched Nov 12, 2026
- Longeveron Mesenchymal Stem Cells (LMSCs)Phase 2 · Aging FrailtyClinicalTrials.gov · fetched Nov 12, 2026
- Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)Phase 2 · FrailtyClinicalTrials.gov · fetched Nov 12, 2026
- Allo-hMSCsPhase 1 · Hypoplastic Left Heart SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Longeveron Mesenchymal Stem CellsPhase 1 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Longeveron Mesenchymal Stem Cells (LMSCs)Phase 1 · ARDS, HumanClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Lomecel-B Effects on Alzheimer's DiseasePHASE2 · COMPLETED · started Dec 28, 2021ClinicalTrials.gov NCT05233774 · fetched Nov 12, 2026
- Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 25, 2021ClinicalTrials.gov NCT04925024 · fetched Nov 12, 2026
- Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)PHASE1 · UNKNOWN · started Jul 24, 2020ClinicalTrials.gov NCT04629105 · fetched Nov 12, 2026
- Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS)PHASE1_PHASE2 · UNKNOWN · started Feb 21, 2018ClinicalTrials.gov NCT03525418 · fetched Nov 12, 2026
- Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging FrailtyPHASE2 · COMPLETED · started Jul 6, 2017ClinicalTrials.gov NCT03169231 · fetched Nov 12, 2026
- Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging FrailtyPHASE1_PHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02982915 · fetched Nov 12, 2026
- Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's DiseasePHASE1 · COMPLETED · started Oct 10, 2016ClinicalTrials.gov NCT02600130 · fetched Nov 12, 2026
- Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart SyndromePHASE1 · TERMINATED · started Apr 1, 2015ClinicalTrials.gov NCT02398604 · fetched Nov 12, 2026
- AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS DeliveryPHASE1_PHASE2 · COMPLETED · started Mar 3, 2014ClinicalTrials.gov NCT02065245 · fetched Nov 12, 2026
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Oct 26, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 23, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 24, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 19, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 29, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 8, 2026 · fetched Nov 12, 2026